Taribavirin clinical trials
Also written Viramidine.
How each study uses taribavirin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses taribavirin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)CompletedPhase 2Bausch Health Americas, Inc.NCT00446134Written as TaribavirinHow we know
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveCompletedPhase 3Bausch Health Americas, Inc.NCT00230958Written as ViramidineHow we know
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedPhase 3Bausch Health Americas, Inc.NCT00093093Written as ViramidineHow we know
- Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis CTerminatedPhase 2Bausch Health Americas, Inc.NCT00305383Written as ViramidineHow we know
Codes
What other systems call taribavirin · ClinicalTrials.gg INT002844
- MeSH (NLM) C026956taribavirinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R3B1994K2ETARIBAVIRINConfirmed FDA, NLM, Wikidata
- Wikidata Q7686009taribavirinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76499TaribavirinOne source FDA
- DrugBank DB06408One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C026956 | taribavirin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R3B1994K2E | TARIBAVIRIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7686009 | taribavirin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76499 | Taribavirin | One source FDA |
| DrugBank | DB06408 | — | One source Wikidata |
Also registered as taribavirin hydrochloride (UNII D22JZE246P).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.